Post-Therapy Pathologic Stage and Survival in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemoradiation

Post-Therapy Pathologic Stage and Survival in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemoradiation

BACKGROUND: Neoadjuvant chemoradiation before surgery is an emerging treatment modality for pancreatic ductal adenocarcinoma (PDAC). However, analysis of prognostic factors is limited for patients with PDAC treated with neoadjuvant chemoradiation and pancreaticoduodenectomy (PD). METHODS: The study...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Estrella, Jeannelyn (author)
مؤلفون آخرون: Rashid, Asif (author), Fleming, Jason (author), Katz, Matthew (author), Lee, Jeffrey (author), Wolff, Robert (author), Varadhachary, Gauri (author), Pisters, Peter (author), Abdalla, Eddie (author), Vauthey, Jean-Nicolas (author), Wang, Hua (author), Gomez, Henry (author), Evans, Douglas (author), Abbruzzese, James (author), Wang, Huamin (author)
التنسيق: article
منشور في: 2011
الوصول للمادة أونلاين:http://hdl.handle.net/10725/2646
http://dx.doi.org/10.1002/cncr.26243
http://onlinelibrary.wiley.com/doi/10.1002/cncr.26243/full
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

الانترنت

http://hdl.handle.net/10725/2646
http://dx.doi.org/10.1002/cncr.26243
http://onlinelibrary.wiley.com/doi/10.1002/cncr.26243/full

مواد مشابهة